Drug – bio-affecting and body treating compositions – Immunoglobulin – antiserum – antibody – or antibody fragment,... – Reduced antigenicity – reduced ability to bind complement – or...
Patent
1980-05-22
1982-03-23
Phillips, Delbert R.
Drug, bio-affecting and body treating compositions
Immunoglobulin, antiserum, antibody, or antibody fragment,...
Reduced antigenicity, reduced ability to bind complement, or...
2601125LH, A61K 3700, C07C10352
Patent
active
043212603
ABSTRACT:
Herein is described a method of treating benign prostatic hyperlasia without affecting testicular weight in a male mammal by administering an effective amount of gonadorelin.
REFERENCES:
A. V. Schally, et al., Am. J. Obstetrics and Gynecology, 114 (1972).
Chem. Abstr. vol. 73, 1970, p. 107506d.
Chem. Abstr. vol. 82, 1975, p. 119295h.
Chem. Abstr. vol. 93, 1980, p. 1242n.
Chem. Abstr. vol. 84, 1976, p. 145684v.
Ayerst McKenna & Harrison, Inc.
Mandel Adley F.
Phillips Delbert R.
LandOfFree
Method of using gonadorelin for the treatment of benign prostati does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Method of using gonadorelin for the treatment of benign prostati, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method of using gonadorelin for the treatment of benign prostati will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1650771